Chang, Emalyn C.

HRN: 25-94-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/23/2024
09/30/2024
IV
500MG
Q8
PMBO
Waiting Final Action 
09/23/2024
CEFTRIAXONE 1G (VIAL)
09/23/2024
09/30/2024
IV
2G
OD
PMBO
Waiting Final Action 
10/12/2024
CEFUROXIME 500MG (TAB)
10/12/2024
10/19/2024
PO
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: